Clinical trial
Antireflux Mucosal Ablation Versus Laparoscopic Nissen Fundoplication for Refractory Gastroesophageal Reflux Disease: A Comparative Cohort Study of 200 Patients
NCT07842354 is registered in ClinicalTrials.gov with Minia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antireflux Mucosal Ablation Versus Laparoscopic Nissen Fundoplication for Refractory Gastroesophageal Reflux Disease: A Comparative Cohort Study of 200 Patients
- Lead sponsor
- Minia University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2023
- Completion date
- December 31, 2024
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antireflux mucosal ablation, endoscopic therapy, laparoscopic fundoplication procedure, refractory gerd